Home Cart Sign in  
Chemical Structure| 89796-99-6 Chemical Structure| 89796-99-6

Structure of Aceclofenac
CAS No.: 89796-99-6

Chemical Structure| 89796-99-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of diclofenac.

Synonyms: Preservex; Airtal; Beofenac

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Aceclofenac

CAS No. :89796-99-6
Formula : C16H13Cl2NO4
M.W : 354.18
SMILES Code : O=C(OCC(O)=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
Synonyms :
Preservex; Airtal; Beofenac
MDL No. :MFCD00864296
InChI Key :MNIPYSSQXLZQLJ-UHFFFAOYSA-N
Pubchem ID :71771

Safety of Aceclofenac

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01912066 NSAID-associated Gastroduodena... More >>l Injury Less << Phase 4 Completed - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of, 614735 Less <<
NCT01952314 Ureter Stones Phase 3 Completed - Korea, Republic of ... More >> Donguk University Ilsan Hospital Goyang, Kyunggi, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Kyunggi, Korea, Republic of, 463-712 Kangwon National University Hospital Chuncheon, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 National Medical Center Seoul, Korea, Republic of Seoul National University Boramae Medical Center Seoul, Korea, Republic of Less <<
NCT02384928 Sciatica Inte... More >>rvertebral Disc Displacement Less << Not Applicable Completed - Korea, Republic of ... More >> Jaseng Hospital of Korean Medicine Seoul, Gangnam-Gu, Korea, Republic of, 135-896 Less <<
NCT00647517 Ankylosing Spondylitis Phase 4 Completed - Taiwan ... More >> Chung Shan Medical University Hospital Taichung, Taiwan, 402 Less <<
NCT02883569 Low Back Pain Not Applicable Recruiting December 2021 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Chi Heon Kim, MD, PhD    +82-2-2072-2358    chiheon1@snu.ac.kr    Principal Investigator: Chun Kee Chung, MD, PhD Less <<
NCT00635349 Osteoarthritis Phase 4 Completed - -
NCT01843946 - Completed - Korea, Republic of ... More >> The Catholic University of Korea, St. Vincent's Hospital Suwon, Korea, Republic of, 442-723 Less <<
NCT01959074 Disorder of Urinary Stent Phase 3 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Kyunggi, Korea, Republic of, 463-712 Kangwon National University Hospital Chuncheon, Korea, Republic of Donguk University Ilsan Hospital Goyang, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 National Medical Center Seoul, Korea, Republic of Seoul National University Boramae Hospital Seoul, Korea, Republic of Less <<
NCT02682524 Osteoarthritis of Knee Phase 4 Completed - Korea, Republic of ... More >> Inha university hospital Chung gu, Incheon, Korea, Republic of Less <<
NCT03127046 Healthy Phase 1 Enrolling by invitation April 23, 2017 Korea, Republic of ... More >> Chonbuk National University Hospital. Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Less <<
NCT02289274 Healthy Phase 1 Suspended(Due to operational r... More >>easons) Less << December 2017 -
NCT01638286 - Completed - -
NCT03335007 Symptomatic Irreversible Pulpi... More >>tis Less << Phase 2 Phase 3 Completed - Egypt ... More >> Cairo University Cairo, Egypt, 11553 Less <<
NCT03146481 Irreversible Pulpitis Phase 2 Phase 3 Completed - Egypt ... More >> Cairo University Cairo, Egypt, 11553 Less <<
NCT01869985 Healthy Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00635349 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.82mL

0.56mL

0.28mL

14.12mL

2.82mL

1.41mL

28.23mL

5.65mL

2.82mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories